What is the level of liabilities of Cipla this year?
Cipla has a debt balance of 60.11 B INR this year.
Cipla Liabilities 2024
Cipla Liabilities
60.11 B INR
Ticker
CIPLA.NS
ISIN
INE059A01026
In 2024, Cipla's total liabilities amounted to 60.11 B INR, a -3.96% difference from the 62.59 B INR total liabilities in the previous year.
Cipla Aktienanalyse
What does Cipla do?
Cipla Ltd is an Indian pharmaceutical company based in Mumbai. The company was founded in 1935 and is now one of the largest producers of generics worldwide. The name "Cipla" is an abbreviation for "Chemical, Industrial & Pharmaceutical Laboratories". Business Model: Cipla specializes in the production of high-quality generics. This means that they manufacture medication that has the same active ingredients as the original drugs. This allows them to offer medication at a significantly lower price. However, Cipla not only offers generics but also develops its own innovative medication. The focus is on therapy areas such as oncology, respiratory diseases, HIV/AIDS, diabetes, and cardiovascular diseases. Divisions: Cipla is divided into several divisions, including generics, specialty drugs, and biologics. The generics division is the company's core competence. Here, Cipla produces a variety of medications in different forms, such as tablets, capsules, suspensions, etc. The specialty drugs division focuses on innovative medications that are usually more expensive than generics. This includes medications for the treatment of cancer or autoimmune diseases. In the biologics division, Cipla produces biotechnology products based on the use of living cells. Products: Cipla offers a wide range of products, including medications for asthma, diabetes, hypertension, and infectious diseases. Some of the most well-known medications are Escitalopram (an antidepressant), Seroflo (an asthma medication), Tenofovir (an HIV medication), and Sorafenib (a cancer medication). The company continuously works on new products and invests heavily in research and development. Cipla also has a social responsibility. The company is involved in the fight against HIV/AIDS and produces life-saving medication for this disease at an affordable price. Furthermore, Cipla has launched a program called "Cipla Foundation" which works towards improving healthcare in developing countries. Overall, Cipla has achieved impressive growth and is now one of the most significant pharmaceutical companies worldwide. The company has proven that it is possible to offer high-quality medication at an affordable price and still be successful. Cipla ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Cipla's Liabilities
Cipla's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cipla's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Cipla's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Cipla's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Cipla’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Cipla stock
What were the liabilities of Cipla compared to the previous year?
The liabilities of Cipla have increased by -3.96% dropped compared to the previous year.
What are the consequences of high debt for investors of Cipla?
High liabilities can pose a risk for investors of Cipla, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Cipla?
Low liabilities mean that Cipla has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Cipla affect the company?
An increase in liabilities of Cipla can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Cipla affect the company?
A decrease in the liabilities of Cipla can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Cipla?
Some factors that can influence the liabilities of Cipla include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Cipla so important for investors?
The liabilities of Cipla are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Cipla take to modify the liabilities?
To change its liabilities, Cipla can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Cipla pay?
Over the past 12 months, Cipla paid a dividend of 13 INR . This corresponds to a dividend yield of about 0.82 %. For the coming 12 months, Cipla is expected to pay a dividend of 14.32 INR.
What is the dividend yield of Cipla?
The current dividend yield of Cipla is 0.82 %.
When does Cipla pay dividends?
Cipla pays a quarterly dividend. This is distributed in the months of September, September, August, September.
How secure is the dividend of Cipla?
Cipla paid dividends every year for the past 23 years.
What is the dividend of Cipla?
For the upcoming 12 months, dividends amounting to 14.32 INR are expected. This corresponds to a dividend yield of 0.9 %.
In which sector is Cipla located?
Cipla is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cipla kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cipla from 9/19/2024 amounting to 13 INR, you needed to have the stock in your portfolio before the ex-date on 8/2/2024.
When did Cipla pay the last dividend?
The last dividend was paid out on 9/19/2024.
What was the dividend of Cipla in the year 2023?
In the year 2023, Cipla distributed 8.5 INR as dividends.
In which currency does Cipla pay out the dividend?
The dividends of Cipla are distributed in INR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cipla
Our stock analysis for Cipla Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cipla Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.